P

Inventor

AKINC AKIN

US61 patents
⚠️ This page may combine multiple inventors who share the name “AKINC AKIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALNYLAM PHARMACEUTICALS INC

28 patents
US7605251B2Oct 20, 2009

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC160 citations99
US11246933B1Feb 15, 2022

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC30 citations98
US10369226B2Aug 6, 2019

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC25 citations98
US9061063B2Jun 23, 2015

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC41 citations98
US7737265B2Jun 15, 2010

RNAi modulation of HIF-1 and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC122 citations98
US11679158B2Jun 20, 2023

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC7 citations94
US11633479B2Apr 25, 2023

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC11 citations94
US11633480B2Apr 25, 2023

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC11 citations94
US11612657B2Mar 28, 2023

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC9 citations94
US11590229B2Feb 28, 2023

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC11 citations94
US11382979B2Jul 12, 2022

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC18 citations94
US10934544B2Mar 2, 2021

Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC15 citations94
US9682922B2Jun 20, 2017

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC39 citations94
US7928217B2Apr 19, 2011

Nuclease resistant double-stranded ribonucleic acid

ALNYLAM PHARMACEUTICALS INC37 citations92
US11071784B2Jul 27, 2021

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC5 citations84
US9822365B2Nov 21, 2017

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC3 citations84
US9687448B2Jun 27, 2017

Nucleic acid lipid particle formulations

ALNYLAM PHARMACEUTICALS INC7 citations84
US9376680B2Jun 28, 2016

Serpinc1 iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC7 citations84
US9260718B2Feb 16, 2016

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC6 citations84
US9415109B2Aug 16, 2016

Stable non-aggregating nucleic acid lipid particle formulations

ALNYLAM PHARMACEUTICALS INC14 citations83
US7871985B2Jan 18, 2011

Compositions and methods for inhibiting expression of factor VII gene

ALNYLAM PHARMACEUTICALS INC5 citations74
US12364762B2Jul 22, 2025

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC0 citations73
US12350338B2Jul 8, 2025

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC0 citations73
US12343398B2Jul 1, 2025

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC0 citations73
US12239709B2Mar 4, 2025

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC0 citations73
US11400158B2Aug 2, 2022

Biodegradable lipids for the delivery of active agents

ALNYLAM PHARMACEUTICALS INC1 citations73
US10501742B2Dec 10, 2019

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC1 citations73
US11208660B1Dec 28, 2021

Coronavirus iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC3 citations70

FITZGERALD KEVIN

3 patents
US9051567B2Jun 9, 2015

Methods for increasing efficacy of lipid formulated siRNA

FITZGERALD KEVIN104 citations97
US8273869B2Sep 25, 2012

Lipid formulated dsRNA targeting the PCSK9 gene

FITZGERALD KEVIN17 citations92
US8598139B2Dec 3, 2013

Lipid formulated dsRNA targeting the PCSK9 gene

FITZGERALD KEVIN15 citations84

MANOHARAN MUTHIAH

2 patents
US8642076B2Feb 4, 2014

Lipid containing formulations

MANOHARAN MUTHIAH155 citations99
US9012498B2Apr 21, 2015

Biodegradable lipids for the delivery of active agents

MANOHARAN MUTHIAH104 citations97

CHEN JIANXIN

2 patents
US8802644B2Aug 12, 2014

Lipid formulation

CHEN JIANXIN124 citations97
US8158601B2Apr 17, 2012

Lipid formulation

CHEN JIANXIN777 citations97

TAN PAMELA

2 patents
US8222222B2Jul 17, 2012

Compositions and methods for inhibiting expression of the PCSK9 gene

TAN PAMELA13 citations92
US8809292B2Aug 19, 2014

Compositions and methods for inhibiting expression of the PCSK9 gene

TAN PAMELA7 citations83

AKINC AKIN

2 patents
US8324366B2Dec 4, 2012

Compositions and methods for delivering RNAI using lipoproteins

AKINC AKIN33 citations91
US8148344B2Apr 3, 2012

Compositions and methods for mediating RNAi in vivo

AKINC AKIN26 citations88

ARBUTUS BIOPHARMA CORP

2 patents
US10053689B2Aug 21, 2018

Methods for increasing efficacy of lipid formulated siRNA

ARBUTUS BIOPHARMA CORP7 citations84
US11420931B2Aug 23, 2022

Lipid containing formulations

ARBUTUS BIOPHARMA CORP2 citations73

MASSACHUSETTS INST TECHNOLOGY

1 patent
US7427394B2Sep 23, 2008

Biodegradable poly(β-amino esters) and uses thereof

MASSACHUSETTS INST TECHNOLOGY172 citations99

TEKMIRA PHARMACEUTICALS CORP

1 patent
US9394234B2Jul 19, 2016

Lipid formulations

TEKMIRA PHARMACEUTICALS CORP117 citations98

ANDERSON DANIEL GRIFFITH

1 patent
USRE43612EAug 28, 2012

Biodegradable poly(β-amino esters) and uses thereof

ANDERSON DANIEL GRIFFITH100 citations98

ALNYLAM PHARMACEUTICALS

1 patent
US9127274B2Sep 8, 2015

Serpinc1 iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS51 citations96

ALNYLAM PHARAMACETICALS INC

1 patent
US8034376B2Oct 11, 2011

Lipid containing formulations

ALNYLAM PHARAMACETICALS INC71 citations94

VORNLOCHER HANS-PETER

1 patent
US8334373B2Dec 18, 2012

Nuclease resistant double-stranded ribonucleic acid

VORNLOCHER HANS-PETER30 citations91

GENZYME CORP

1 patent
US11091759B2Aug 17, 2021

Methods and compositions for treating a Serpinc1-associated disorder

GENZYME CORP31 citations87

BETTENCOURT BRIAN

1 patent
US9228188B2Jan 5, 2016

Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

BETTENCOURT BRIAN8 citations82

MARCUSSON ERIC G

1 patent
US8846631B2Sep 30, 2014

MicroRNA compositions and methods

MARCUSSON ERIC G9 citations79

Showing the top 50 of 61 patents by PatentIndex Score.